Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Pain Symptom Manage. 2017 Dec 6;55(4):1138–1151.e1. doi: 10.1016/j.jpainsymman.2017.11.030

Table 4.

Results of unadjusted and adjusted logistic regression analyses that evaluated for differences between premenopausal and postmenopausal women in symptom occurrence rates with interaction effects 12 months after breast cancer surgery

LOGISTIC REGRESSION RESULTS
Symptom Covariates Unadjusted Model Adjusted Model
OR CI p-value OR CI p-value
Logistic Regression Results for Total Sample
Hot flashes
PRE = 58.3%
POST = 45.3%
Overall Model
X2=59.53; p<.001
Menopausal status* 0.56 0.35, 0.89 .015 5681.12 136.43, 236576.94 <.001
Age (in 5 year increments) 1.38 1.00, 1.92 .050
Lives alone 0.92 0.51, 1.65 .770
Working for pay 0.65 0.39, 1.07 .089
SCQ score 1.07 0.97, 1.17 .188
Prior HRT 2.19 1.1 0, 4.36 .026
Adjuvant chemotherapy during 12 months 1.11 0.66, 1.87 .692
Radiation therapy during 12 months 1.11 0.59, 2.1 0 .739
Reconstruction during 12 months 1.52 0.63, 3.68 .352
Type of surgery: conservation (ref) vs mastectomy 0.96 0.44, 2.1 0 .921
Age × menopausal status 0.42 0.29, 0.61 .000
Adjusted Regression of Hot Flashes Occurrence on Age, Stratified by Menopausal Status
Premenopausal 1.43 0.99, 2.06 .055
Postmenopausal 0.56 0.46, 0.69 <.001
Night Sweats
PRE = 44.3%
POST = 32.5%
Overall Model
X2=41.70; p<.001
Menopausal status* 0.59 0.37, 0.94 .026 1132.50 29.38, 43655.1 <.001
Age (in 5 year increments) 1.3 0 0.94, 1.8 0 .117
Lives alone 1.05 0.57, 1.92 .872
Working for pay 0.97 0.59, 1.59 .892
SCQ score 1.04 0.95, 1.15 .397
Prior HRT 2.35 1.18, 4.67 .015
Adjuvant chemotherapy during 12 months 1.04 0.62, 1.75 .872
Radiation therapy during 12 months 0.85 0.45, 1.62 .632
Reconstruction during 12 months 0.91 0.38, 2.2 0 .837
Type of surgery: conservation (ref) vs mastectomy 1.28 0.58, 2.82 .536
Age × menopausal status 0.49 0.34, 0.71 <.001
Adjusted Regression of Night Sweats Occurrence on Age, Stratified by Menopausal Status
Premenopausal 1.31 0.92, 1.88 .140
Postmenopausal 0.63 0.52, 0.76 <.001
Depression
PRE = 34.5%
POST = 24.5%
Overall Model
X2 =30.92; p=.001
Menopausal status* 0.60 0.37, 0.99 .047 338.93 6.92, 16611.16 .003
Age (in 5 year increments) 1.41 0.98, 2.02 .061
Lives alone 0.89 0.47, 1.71 .733
Working for pay 1.02 0.60, 1.73 .937
SCQ score 1.18 1.07, 1.30 .001
Prior HRT 0.83 0.39, 1.76 .620
Adjuvant chemotherapy during 12 months 1.04 0.60, 1.79 .889
Radiation therapy during 12 months 0.82 0.42, 1.61 .571
Reconstruction during 12 months 1.19 0.47, 2.98 .717
Type of surgery: conservation (ref) vs mastectomy 1.16 0.51, 2.64 .725
Age × menopausal status 0.54 0.36, 0.8 0 .002
Adjusted Regression of Depression Occurrence on Age, Stratified by Menopausal Status
Premenopausal 1.50 1.00, 2.25 .048
Postmenopausal 0.77 0.64, 0.92 .003
Daytime sweats
PRE = 39.7%
POST = 26.9%
Overall Model
X2=34.535; p=.011
Menopausal status* 0.53 0.33, 0.87 .011 137.20 3.53, 5329.31 .008
Age (in 5 year increments) 1.3 0 0.93, 1.83 .121
Lives alone 0.78 0.42, 1.47 .446
Working for pay 0.91 0.54, 1.51 .705
SCQ score 1.08 0.98, 1.19 .122
Prior HRT 2.92 1.46, 5.83 .002
Adjuvant chemotherapy during 12 months 0.98 0.57, 1.66 .931
Radiation therapy during 12 months 1.21 0.61, 2.39 .581
Reconstruction during 12 months 0.62 0.24, 1.56 .308
Type of surgery: conservation (ref) vs mastectomy 2.18 0.97, 4.93 .060
Age × menopausal status 0.57 0.39, 0.83 .004
Adjusted Regression of Daytime Sweats Occurrence on Age, Stratified by Menopausal Status
Premenopausal 1.27 0.89, 1.81 .190
Postmenopausal 0.74 0.63, 0.89 .001
Joint pain or stiffness
PRE = 40.0%
POST = 51.9%
Overall Model
X2=23.66; p=.014
Menopausal status* 1.62 1.02, 2.57 .043 387.32 6.64, 22601.80 .004
Age (in 5 year increments) 1.88 1.26, 2.79 .002
Lives alone 0.97 0.56, 1.68 .906
Working for pay 0.89 0.55, 1.42 .614
SCQ score 1.07 0.98, 1.17 .133
Prior HRT 1.00 0.54, 1.86 .993
Adjuvant chemotherapy during 12 months 1.40 0.85, 2.32 .188
Radiation therapy during 12 months 0.63 0.34, 1.17 .145
Reconstruction during 12 months 1.31 0.54, 3.16 .551
Type of surgery: conservation (ref) vs mastectomy 0.61 0.28, 1.31 .206
Age × menopausal status 0.54 0.36, 0.83 .004
Adjusted Regression of Joint Pain Occurrence on Age, Stratified by Menopausal Status
Premenopausal 2.07 1.33, 3.23 .001
Postmenopausal 1.00 0.86, 1.15 .947
Wake during the night
PRE = 61.7%
POST = 63.7%
Overall Model
X2=23.12; p=.017
Menopausal status* 1.08 0.67, 1.73 .764 149.89 4.59, 4893.95 .005
Age (in 5 year increments) 1.25 0.91, 1.72 .170
Lives alone 0.92 0.52, 1.63 .779
Working for pay 0.64 0.39, 1.05 .079
SCQ score 1.10 1.00, 1.21 .058
Prior HRT 1.29 0.67, 2.48 .447
Adjuvant chemotherapy during 12 months 0.90 0.53, 1.51 .678
Radiation therapy during 12 months 1.06 0.57, 1.97 .855
Reconstruction during 12 months 2.53 0.99, 6.47 .052
Type of surgery: conservation (ref) vs mastectomy 0.7 0 0.32, 1.54 .380
Age × menopausal status 0.62 0.44, 0.88 .008
Adjusted Regression of Wake During the Night Occurrence on Age, Stratified by Menopausal Status
Premenopausal 1.29 0.92, 1.80 .142
Postmenopausal 0.76 0.64, 0.90 .001
Numbness or tingling
PRE = 27.8%
POST = 29.7%
Overall Model
X2=29.37; p=.002
Menopausal status* 1.12 0.67, 1.86 .673 174.64 3.33, 9171.79 .011
Age (in 5 year increments) 1.29 0.89, 1.87 .185
Lives alone 1.52 0.83, 2.79 .174
Working for pay 0.74 0.44, 1.24 .253
SCQ score 1.08 0.98, 1.18 .143
Prior HRT 1.05 0.52, 2.12 .900
Adjuvant chemotherapy during 12 months 2.47 1.45, 4.20 .001
Radiation therapy during 12 months 0.82 0.42, 1.6 0 .562
Reconstruction during 12 months 1.06 0.42, 2.67 .905
Type of surgery: conservation (ref) vs mastectomy 1.16 0.52, 2.6 0 .710
Age × menopausal status 0.62 0.41, 0.92 .019
Adjusted Regression of Numbness or Tingling Occurrence on Age, Stratified by Menopausal Status
Premenopausal 1.32 0.88, 1.98 .176
Postmenopausal 0.79 0.66, 0.93 .006

Abbreviations: CI = confidence interval; HRT = hormone replacement therapy; OR = odds ratio; PRE = premenopausal; POST = postmenopausal; ref = reference group; SCQ = Self-administered Comorbidity Questionnaire; vs = versus

*

reference group = premenopausal women